Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Collegium Pharmaceutical, Inc. (COLL : NSDQ)
 
 • Company Description   
Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171, COL-003 and COL-172 which are in different clinical trial. It developed a formulation platform technology, DETERx, for the treatment of chronic pain. Collegium Pharmaceutical Inc. is based in CUMBERLAND, United States.

Number of Employees: 423

 
 • Price / Volume Information   
Yesterday's Closing Price: $34.07 Daily Weekly Monthly
20 Day Moving Average: 465,218 shares
Shares Outstanding: 32.43 (millions)
Market Capitalization: $1,105.03 (millions)
Beta: 0.76
52 Week High: $50.79
52 Week Low: $28.34
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 5.55% 0.39%
12 Week -22.95% -28.77%
Year To Date -26.41% -31.65%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
100 Technology Center Drive
-
Stoughton,MA 02072
USA		 ph: 781-713-3699
fax: -		 ir@collegiumpharma.com http://www.collegiumpharma.com
 
 • General Corporate Information   
Officers
Vikram Karnani - Chief Executive Officer and President
Gino Santini - Chairman
Colleen Tupper - Executive Vice President and Chief Financial Offic
Rita Balice-Gordon - Director
Garen G. Bohlin - Director

Peer Information
Collegium Pharmaceutical, Inc. (GSAC)
Collegium Pharmaceutical, Inc. (CASIF)
Collegium Pharmaceutical, Inc. (ALCD.)
Collegium Pharmaceutical, Inc. (OMNN)
Collegium Pharmaceutical, Inc. (CGPI.)
Collegium Pharmaceutical, Inc. (CATX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 19459J104
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/06/26
Share - Related Items
Shares Outstanding: 32.43
Most Recent Split Date: (:1)
Beta: 0.76
Market Capitalization: $1,105.03 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $1.48 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $6.76 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/06/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 5.04
Trailing 12 Months: 4.95
PEG Ratio: -
Price Ratios
Price/Book: 3.54
Price/Cash Flow: 2.24
Price / Sales: 1.39
EPS Growth
vs. Year Ago Period: 21.95%
vs. Previous Quarter: -18.92%
Sales Growth
vs. Year Ago Period: 8.87%
vs. Previous Quarter: -5.81%
ROE
03/31/26 - 95.18
12/31/25 - 98.65
09/30/25 - 102.03
ROA
03/31/26 - 16.39
12/31/25 - 15.86
09/30/25 - 15.24
Current Ratio
03/31/26 - 1.71
12/31/25 - 1.57
09/30/25 - 1.36
Quick Ratio
03/31/26 - 1.62
12/31/25 - 1.48
09/30/25 - 1.27
Operating Margin
03/31/26 - 33.50
12/31/25 - 32.96
09/30/25 - 32.69
Net Margin
03/31/26 - 9.41
12/31/25 - 8.05
09/30/25 - 7.72
Pre-Tax Margin
03/31/26 - 13.59
12/31/25 - 11.87
09/30/25 - 10.68
Book Value
03/31/26 - 9.63
12/31/25 - 9.54
09/30/25 - 8.72
Inventory Turnover
03/31/26 - 7.84
12/31/25 - 8.22
09/30/25 - 8.70
Debt-to-Equity
03/31/26 - 2.47
12/31/25 - 2.59
09/30/25 - 2.71
Debt-to-Capital
03/31/26 - 71.14
12/31/25 - 72.12
09/30/25 - 73.01
 

Powered by Zacks Investment Research ©